Search clinical trials for: Ruxolitinib 25 mg
Total 10938 results
-
Incyte CorporationTerminatedMPN (Myeloproliferative Neoplasms)United States
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedA Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic DermatitisAtopic DermatitisUnited States, Canada
-
Novartis PharmaceuticalsCompletedMyelofibrosisFrance, United Kingdom, Belgium, Germany, Netherlands, Italy, Austria, Spain, Sweden
-
Novartis PharmaceuticalsCompleted
-
Sheba Medical CenterTerminated
-
Intercept PharmaceuticalsCompleted
-
Fortuderm Ltd.UnknownPsoriasis VulgarisIsrael
-
French Innovative Leukemia OrganisationCompleted
-
Medicines for Malaria VentureNucleus Network Ltd; Southern Star Research Pty Ltd.Completed
-
Mylan Pharmaceuticals IncCompleted
-
Pharmtechnology LLCLigand Research, LLCCompleted
-
CORTESI LAURAUnknown
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingKohlmeier Degos Disease With Neurologic InvolvementUnited States
-
University of NebraskaCompletedGraft-versus-host-disease (GVHD)United States
-
Gilead SciencesCompleted
-
Washington University School of MedicineIncyte CorporationWithdrawnCOVID-19
-
Yuhan CorporationCompleted
-
EpicentreMedecins Sans Frontieres, SpainCompletedMalaria, FalciparumCongo, The Democratic Republic of the
-
Mylan Pharmaceuticals IncCompleted
-
Kartos Therapeutics, Inc.RecruitingMyelofibrosisUnited States, France, Australia, Spain, Germany, Bulgaria, Israel, Italy, Poland
-
Incyte CorporationInnovaderm ResearchCompleted
-
The First Affiliated Hospital of Soochow UniversityUnknownSafety and EfficacyChina
-
University of CologneCompletedRecurrent Classical Hodgkin LymphomaGermany
-
Masimo CorporationCompleted
-
AstraZenecaCompletedHealthy Subjects | BioavailabilityGermany
-
Teva Pharmaceuticals USACompletedHealthyUnited States
-
Niguarda HospitalRecruitingCLL TransformationItaly, Switzerland
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisGermany
-
Incyte CorporationNovartisCompletedMyelofibrosisFrance, United Kingdom, China, United States, Netherlands, Germany, Italy, Austria
-
Novartis PharmaceuticalsCompletedAsian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MFPrimary Myelofibrosis (MF) | Post-Polycythemia Vera (PV) MF | Post-Essential Thrombocythemia (ET) MFTaiwan, Japan, Korea, Republic of, China
-
HK inno.N CorporationRecruitingPreventive Peptic UlcerKorea, Republic of
-
New York State Psychiatric InstituteClinilabs, Inc.Recruiting
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, China, Japan, France, Turkey, Germany, Israel, Poland, Belgium, Italy, Austria, Denmark, Finland, Norway
-
Novartis PharmaceuticalsCompleted
-
Incyte CorporationCompletedCutaneous Lichen PlanusUnited States, Canada
-
Teva Pharmaceuticals USACompleted
-
Idorsia Pharmaceuticals Ltd.CompletedPharmacokinetics | Pharmacodynamics | Tolerability | SafetyNetherlands
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, Belgium, France, Israel, China, Japan, Italy, Germany, Taiwan, Poland, Austria, Finland, Hungary, Norway, Romania, Turkey
-
Incyte CorporationCompletedHidradenitis SuppurativaUnited States, Canada
-
Incyte CorporationCompletedLichen SclerosusUnited States, Canada
-
Novartis PharmaceuticalsCompletedAcute Graft Versus Host DiseaseBelgium, Japan, Spain, France, Korea, Republic of, Canada, Italy, Denmark
-
National Cancer Institute (NCI)TerminatedLeukemia, Adult T-Cell | T Cell Leukemia, Adult | T Cell Leukemia, HTLV I AssociatedUnited States